Fradet, Yves

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

Bellmunt, J., de Wit, R., Vaughn, D. J., Fradet, Y., Lee, J.-L., Fong, L., Vogelzang, N. J., Climent, M. A., Petrylak, D. P., Choueiri, T. K., et al. (2017) · New England Journal of Medicine

Bladder and Urothelial Cancer TreatmentsCancer Immunotherapy and Biomarkers

Cited by 3,395

Widespread and Functional RNA Circularization in Localized Prostate Cancer

Chen, S., Huang, V., Xu, X., Livingstone, J., Soares, F., Jeon, J., Zeng, Y., Hua, J. T., Petricca, J., Guo, H., et al. (2019) · Cell

Circular RNAs in diseasesRNA Research and Splicing

Cited by 544

PD‐L1 (B7‐H1) expression by urothelial carcinoma of the bladder and BCG‐induced granulomata: Associations with localized stage progression

Inman, B. A., Sebo, T. J., Frigola, X., Dong, H., Bergstralh, E. J., Frank, I., Fradet, Y., Lacombe, L., & Kwon, E. D. (2007) · Cancer

Bladder and Urothelial Cancer TreatmentsCancer Immunotherapy and Biomarkers

Cited by 438

Hexaminolevulinate Guided Fluorescence Cystoscopy Reduces Recurrence in Patients With Nonmuscle Invasive Bladder Cancer

Stenzl, A., Burger, M., Fradet, Y., Mynderse, L. A., Soloway, M. S., Witjes, J. A., Kriegmair, M., Karl, A., Shen, Y., & Grossman, H. B. (2010) · Journal of Urology

Bladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology Studies

Cited by 304

A Phase III, Multicenter Comparison of Hexaminolevulinate Fluorescence Cystoscopy and White Light Cystoscopy for the Detection of Superficial Papillary Lesions in Patients With Bladder Cancer

Grossman, H. B., Gomella, L., Fradet, Y., Morales, A., Presti, J., Ritenour, C., Nseyo, U., Droller, M. J., & PC B302/01 Study Group (2007) · Journal of Urology

Bladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology Studies

Cited by 300

A Natural Polyphenol Exerts Antitumor Activity and Circumvents Anti–PD-1 Resistance through Effects on the Gut Microbiota

Messaoudene, M., Pidgeon, R., Richard, C., Ponce, M., Diop, K., Benlaifaoui, M., Nolin-Lapalme, A., Cauchois, F., Malo, J., Belkaid, W., et al. (2022) · Cancer Discovery

Cancer Immunotherapy and BiomarkersGut microbiota and health

Cited by 250

Tn-MUC1 DC Vaccination of Rhesus Macaques and a Phase I/II Trial in Patients with Nonmetastatic Castrate-Resistant Prostate Cancer

Scheid, E., Major, P., Bergeron, A., Finn, O. J., Salter, R. D., Eady, R., Yassine-Diab, B., Favre, D., Peretz, Y., Landry, C., et al. (2016) · Cancer Immunology Research

Immunotherapy and Immune ResponsesGlycosylation and Glycoproteins Research

Cited by 72

Impact of bone-targeted therapies in chemotherapy-naïve metastatic castration-resistant prostate cancer patients treated with abiraterone acetate: post hoc analysis of study COU-AA-302

Saad, F., Shore, N., Van Poppel, H., Rathkopf, D. E., Smith, M. R., de Bono, J. S., Logothetis, C. J., de Souza, P., Fizazi, K., Mulders, P. F. A., et al. (2015) · European Urology

Prostate Cancer Treatment and ResearchBone health and treatments

Cited by 63